Solabia Acquires Majority Stake in Ethical Naturals
The deal expands Solabia's nutraceutical ingredients platform and its footprint in the U.S. market.
Updated on Nov. 16, 2026 in Organic Food

Solabia has acquired a majority stake in California-based Ethical Naturals Inc., a company that develops and markets nutraceutical ingredients. Ethical Naturals founders Cal Bewicke and Leo Liu will remain shareholders and continue managing the company alongside Solabia.
Why it matters
The move reflects Solabia's strategic repositioning toward cosmetics, nutrition, and life sciences. The partnership is expected to strengthen its nutraceutical ingredients platform and expand its presence in the U.S. market.
The announcement describes Ethical Naturals as a nutraceutical ingredients developer and marketer founded in 2006, with a portfolio spanning four branded ingredients. Financial terms of the majority stake were not disclosed in the source material.
The players
Solabia
Solabia is a French life sciences company active in cosmetics, nutrition, and life sciences, which is repositioning its business toward those areas.
Ethical Naturals Inc.
Ethical Naturals Inc. is a California-based developer and marketer of nutraceutical ingredients, founded in 2006.
The details
Solabia acquired a majority stake in California-based Ethical Naturals Inc., which develops and markets nutraceutical ingredients including AlphaWave L-Theanine, GreenGrown Glucosamine, PureLeaf Ginkgo, and Cranberex Cranberry Extract. The partnership is expected to accelerate growth, particularly in the United States, and to draw on Solabia's scientific expertise to expand across Europe.
Timeline
June 2026: Solabia acquired Mibelle Biochemistry.
August 2026: Astorg acquired Oxoid Remel Microbiology, a unit Solabia plans to divest its microbiological diagnostics division to.
October 29, 2026: Muriel Koch takes effect as Solabia's President and CEO, succeeding Jean-Baptiste Dellon.
Industry Dynamics
The Ethical Naturals deal extends a 2026 run of Solabia acquisitions, including Mibelle Biochemistry and the Xebios Diagnostics Group, as the company consolidates around cosmetics, nutrition, and life sciences. It also follows the company's planned divestment of its microbiological diagnostics division to Oxoid Remel Microbiology.
For consumers, the deal may eventually affect which nutraceutical ingredients appear in supplements sold in the United States and Europe, though no product or pricing changes were announced. Shoppers comparing ingredient-branded supplements may see these brands distributed through a larger network over time.
The takeaway
Solabia's acquisitions show how ingredient suppliers are consolidating to offer broader portfolios across nutrition and life sciences. Readers following supplement ingredients can watch for product-line changes as these combined platforms expand.
Further reading
For more on how the ingredients behind this deal fit into the wider market, see Organic Food.







